[8] His laboratory helped to show how neurotransmitters activate different receptor subtypes in and around synapses, and resolved some controversies about the mechanisms of long-term changes in synaptic strength.

[8] Genetic and autoimmune disorders of synaptic proteins (‘synaptopathies’) provide insights into the mechanisms of a broad range of neurological diseases including epilepsy and migraine.

[8][2] The Kullmann lab[2][7] has contributed to the discovery and elucidation of silent synapses,[9] glutamate spillover, tonic inhibition,[10] long-term potentiation in interneurons,[11] neurological channelopathies[12] and Synaptopathies, gene therapy for epilepsy,[13] and mechanisms of neural oscillations.

[21] "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License."

--Royal Society Terms, conditions and policies at the Wayback Machine (archived 2016-11-11) This article incorporates text available under the CC BY 4.0 license.